Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.

Clover Health Investments, Corp.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

BUSINESS HIGHLIGHTS: GENERATES THIRD QUARTER YEAR-TO-DATE POSITIVE ADJUSTED EBITDA PROFITABILITY, ON A WIDE NETWORK, WHILE GROWING MEMBERSHIP BY 35% AND REVENUE BY 39% YEAR-OVER-YEAR, DESPITE A GREATER PROPORTION OF NEW MEMBERS RELATIVE TO RETURNING MEMBER BASE HIGH COVERAGE OF CLOVER ASSISTANT, INCLUDING WITHIN NEW COHORTS, WILL RESULT IN IMPROVED TOTAL COST OF CARE STRONG RETENTION, ABOVE-MARKET GROWTH, AND PROFITABLE RETURNING MEMBER COHORTS POSITION CLOVER FOR IMPROVED POSITIVE FY26 FINANCIAL RESULTS FINANCIAL RESULTS: THIRD QUARTER 2025 MEDICARE ADVANTAGE MEMBERSHIP OF 109,226, UP 35% YEAR-OVER-YEAR THIRD QUARTER 2025 TOTAL REVENUES OF $497 MILLION, UP 50% YEAR-OVER-YEAR THIRD QUARTER 2025 PROFITABILITY METRICS INCLUDE GAAP NET LOSS OF $24 MILLION, ADJUSTED EBITDA OF $2 MILLION, AND ADJUSTED NET INCOME OF $2 MILLION THIRD QUARTER YEAR-TO-DATE GAAP NET LOSS OF $36 MILLION , ADJUSTED EBITDA OF $45 MILLION , AND ADJUSTED NET INCOME OF $44 MILLION REVISED FULL YEAR 2025 GUIDANCE: INCREASES AVERAGE MEDICARE ADVANTAGE MEMBERSHIP TO 106,000 - 108,000, REPRESENTING 33% GROWTH YEAR-OVER-YEAR AT THE MIDPOINT INCREASES INSURANCE REVENUE TO BETWEEN $1.850BILLION AND $1.880BILLION, REPRESENTING 39% GROWTH YEAR-OVER-YEAR AT THE MIDPOINT IMPROVES ADJUSTED SG&A TO BETWEEN $325MILLION AND $335MILLION, REPRESENTING ADJUSTED SG&A AS A PERCENTAGE OF TOTAL REVENUES BETWEEN 17% - 18% EXPECTS ADJUSTED EBITDA PROFITABILITY BETWEEN $15MILLION AND $30MILLION EXPECTS ADJUSTED NET INCOME BETWEEN $15MILLION AND $30MILLION EXPECTS INSURANCE BER BETWEEN 90% - 91% DIRECTIONAL FULL YEAR 2026 OUTLOOK: COMPANY INTENDS TO MAINTAIN STRONG, SUSTAINABLE GROWTH, SIMILAR TO 2025 STRONG START TO AEP WITH HIGH APPLICATIONS IN CORE MARKETS. HIGH EXPECTED RETENTION EXPECT STRONG RETURNING MEMBER COHORT ECONOMICS, 4.0 STAR PAYMENT YEAR, FAVORABLE CMS RATE UPDATE, INCREASED PART D DIRECT SUBSIDY WILL ENABLE INCREASING ADJUSTED EBITDA PROFITABILITY WILMINGTON, DEL.

CLOVER HEALTH REPORTS THIRD QUARTER 2025 RESULTS

WILMINGTON, DEL., OCT. 31, 2025 (GLOBE NEWSWIRE) -- CLOVER HEALTH INVESTMENTS, CORP. (NASDAQ: CLOV) (CLOVER, CLOVER HEALTH OR THE COMPANY) TODAY ANNOUNCED THAT CHELSEA CLINTON, THE LONGEST-SERVING MEMBER OF ITS BOARD OF DIRECTORS, HAVING JOINED THE BOARD IN EARLY 2017, WILL CONCLUDE HER SERVICE AS OF OCTOBER 31, 2025.

CLOVER HEALTH ANNOUNCES CHELSEA CLINTON TO STEP DOWN FROM BOARD FOLLOWING EIGHT YEARS OF SERVICE

NEW WHITEPAPER DEMONSTRATES HOW CA ENABLES PRIMARY CARE TEAMS IN RESOURCE-CONSTRAINED SETTINGS TO PREVENT, DETECT, AND MANAGE CHRONIC DISEASE. NEW WHITEPAPER DEMONSTRATES HOW CA ENABLES PRIMARY CARE TEAMS IN RESOURCE-CONSTRAINED SETTINGS TO PREVENT, DETECT, AND MANAGE CHRONIC DISEASE.

PRIMARY CARE PHYSICIAN USE OF COUNTERPART ASSISTANT (CA) TECHNOLOGY ASSOCIATED WITH EARLIER DIAGNOSIS AND LESS FREQUENT HOSPITALIZATION IN UNDERSERVED POPULATIONS

WILMINGTON, DEL., OCT. 22, 2025 (GLOBE NEWSWIRE) -- CLOVER HEALTH INVESTMENTS, CORP. (NASDAQ: CLOV) (CLOVER, CLOVER HEALTH OR THE COMPANY), TODAY ANNOUNCED THAT ITS CHIEF FINANCIAL OFFICER, PETER KUIPERS, WILL PRESENT AT THE 2025 UBS GLOBAL HEALTHCARE CONFERENCE ON TUESDAY, NOVEMBER 11, 2025, AT 11:00 A.M. EASTERN TIME.

CLOVER HEALTH TO PARTICIPATE IN UPCOMING 2025 UBS GLOBAL HEALTHCARE CONFERENCE

THE COMPANY REINFORCES MARKET POSITION, MAINTAINING COMPREHENSIVE PPO PORTFOLIO AS CLOVER ASSISTANT DRIVES SUSTAINABLE VALUE THE COMPANY REINFORCES MARKET POSITION, MAINTAINING COMPREHENSIVE PPO PORTFOLIO AS CLOVER ASSISTANT DRIVES SUSTAINABLE VALUE

CLOVER HEALTH'S 2026 MEDICARE ADVANTAGE PLANS CHAMPION AFFORDABILITY AND CHOICE

TECHNOLOGY PLATFORM AGAIN POWERS TOP-TIER HEDIS RESULTS FOR CLOVER HEALTH MEDICARE ADVANTAGE PLANS TECHNOLOGY PLATFORM AGAIN POWERS TOP-TIER HEDIS RESULTS FOR CLOVER HEALTH MEDICARE ADVANTAGE PLANS

COUNTERPART HEALTH EXPANDS PROVEN FLYWHEEL FOR HEDIS EXCELLENCE TO THIRD-PARTY PARTNERS

COMPANY UNDERSCORES DIFFERENTIATED BUSINESS MODEL; REITERATES CONFIDENCE IN ITS ABILITY TO DRIVE ABOVE-MARKET MEMBERSHIP GROWTH AND INCREASING ADJUSTED EBITDA PROFITABILITY1 THROUGH 2027, INDEPENDENT OF STAR RATINGS

CLOVER HEALTH COMMENTS ON 2026 MEDICARE ADVANTAGE STAR RATINGS AND TRAJECTORY FOR INCREASING PROFITABILITY INTO 2027

WILMINGTON, DEL., OCT. 07, 2025 (GLOBE NEWSWIRE) -- CLOVER HEALTH INVESTMENTS, CORP. (NASDAQ: CLOV) (CLOVER, CLOVER HEALTH OR THE COMPANY), A PHYSICIAN ENABLEMENT COMPANY DEDICATED TO BRINGING ACCESS TO GREAT HEALTHCARE TO EVERYONE ON MEDICARE, TODAY ANNOUNCED THAT IT WILL RELEASE ITS FINANCIAL RESULTS AFTER THE MARKET CLOSES ON TUESDAY, NOVEMBER 4, 2025.

CLOVER HEALTH TO REPORT THIRD QUARTER 2025 FINANCIAL RESULTS ON NOVEMBER 4, 2025

NEW VP BLAINE LINDSEY TO DRIVE NATIONAL ENTERPRISE GROWTH; GULF REGION PRESIDENT SHANNON JACOBS TO SCALE OPERATIONS IN HIGH-NEED MARKETS NEW VP BLAINE LINDSEY TO DRIVE NATIONAL ENTERPRISE GROWTH; GULF REGION PRESIDENT SHANNON JACOBS TO SCALE OPERATIONS IN HIGH-NEED MARKETS

COUNTERPART HEALTH EXPANDS LEADERSHIP TO ACCELERATE ENTERPRISE PARTNERSHIPS AND REGIONAL ADOPTION OF AI-POWERED PLATFORM COUNTERPART ASSISTANT

SAN FRANCISCO, SEPT. 25, 2025 (GLOBE NEWSWIRE) -- COUNTERPART HEALTH,INC. (COUNTERPART), A WHOLLY OWNED SUBSIDIARY OF CLOVER HEALTH INVESTMENTS, CORP. (NASDAQ:CLOV) (CLOVER, CLOVERHEALTH OR THE COMPANY) AND A LEADING AIPOWERED PHYSICIANENABLEMENT PLATFORM, TODAY ANNOUNCED THE NEXT STEP IN THE EVOLUTION OF ITS FLAGSHIP COUNTERPART ASSISTANT (CA): GENERATIVE AI CAPABILITIES THAT LET CLINICIANS ENGAGE WITH A PATIENT'S LONGITUDINAL DATA IN REAL TIME THROUGH AI CHAT.

COUNTERPART ASSISTANT GETS CONVERSATIONAL

DR. DUNCAN'S APPOINTMENT TO THIS PRESTIGIOUS ROLE RECOGNIZES HIS EXTRAORDINARY CONTRIBUTIONS TO THE ACTUARIAL PROFESSION AND HEALTHCARE INNOVATION OVER THREE DECADES DR. DUNCAN'S APPOINTMENT TO THIS PRESTIGIOUS ROLE RECOGNIZES HIS EXTRAORDINARY CONTRIBUTIONS TO THE ACTUARIAL PROFESSION AND HEALTHCARE INNOVATION OVER THREE DECADES

CLOVER HEALTH CELEBRATES THE ELECTION OF DR. IAN DUNCAN, CLOVER MA BOARD MEMBER, AS THE 2025-2026 PRESIDENT-ELECT AND VICE-CHAIR OF THE SOCIETY OF ACTUARIES

CLOVER HEALTH CONTINUES TO INVEST IN STREAMLINING PROVIDER WORKFLOWS AND REDUCING ADMINISTRATIVE BURDEN THROUGH TECHNOLOGY AND OPERATIONAL IMPROVEMENTS CLOVER HEALTH CONTINUES TO INVEST IN STREAMLINING PROVIDER WORKFLOWS AND REDUCING ADMINISTRATIVE BURDEN THROUGH TECHNOLOGY AND OPERATIONAL IMPROVEMENTS

CLOVER HEALTH LAUNCHES NEW PORTAL AVAILITY ESSENTIALS TO EMPOWER PROVIDERS AND IMPROVE THE PATIENT EXPERIENCE

WASHINGTON, D.C., SEPT. 03, 2025 (GLOBE NEWSWIRE) -- CLOVER HEALTH INVESTMENTS, CORP. (NASDAQ: CLOV) (CLOVER, CLOVER HEALTH OR THE COMPANY)  CLOVER HEALTH CEO ANDREW TOY TODAY HAD THE HONOR TO DELIVER TESTIMONY BEFORE THE U.S. HOUSE OF REPRESENTATIVES COMMITTEE ON ENERGY AND COMMERCE SUBCOMMITTEE ON HEALTH, POSITIONING CLOVER AS A NATIONAL LEADER IN AI-ENABLED HEALTHCARE TRANSFORMATION.

Clover Health Investments, Corp.

CLOV

Price

Financials Overview

Financial Reports

No items found.

Press Releases

Clover Health Investments, Corp.

CLOV.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

CLOV